Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. on August 11, 2016. The filing discloses the company's financial results for the three and six months ended June 30, 2016, along with updates on clinical programs and business highlights. Note: The input metadata references "Palisade Bio, Inc.", but the filing text explicitly identifies the registrant as Neuralstem, Inc.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a notification that these results were reported in a press release attached as Exhibit 99.01, which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not contain specific data to compare current period performance against prior comparable periods. It only confirms that results for the three and six months ended June 30, 2016, were announced.
Guidance, Outlook, and Risks
The company provided an update on clinical programs and business highlights in the referenced press release. The filing includes a standard disclaimer stating that the information furnished under Item 2.02 and Exhibit 99.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of such section.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing the attached Press Release (Exhibit 99.01) dated August 11, 2016.
- Confirm the status of clinical programs and business highlights mentioned in the press release.
- Note the discrepancy between the metadata company name (Palisade Bio, Inc.) and the filing registrant (Neuralstem, Inc.).
- Review the full text of the press release for any forward-looking statements or risk factors not detailed in this summary.